期刊文献+

吖啶橙荧光染色法在循环肿瘤细胞筛查中的应用 被引量:1

The application of acridine orange fluorescent staining method in circulating tumor cell
下载PDF
导出
摘要 目的应用吖啶橙荧光(AO-F)染色法搭建循环肿瘤细胞(CTCs)筛选平台,并将其应用于肾癌患者外周血CTCs筛查。方法选择转移性肾细胞癌患者27例(研究组),用不同浓度的血清培养肾癌原代肿瘤细胞和细胞系769-P,分别制备涂片于荧光显微镜下,观察细胞形态及着色情况是否一致;随机计数5个视野下AO-F阳性(+)细胞占769-P细胞的比例,评估AO-F染料对肿瘤细胞的敏感性;清晨抽取10例健康体检者(对照组)空腹外周血,红细胞裂解后富集单个核细胞,配制含1×106个细胞的悬液;取对数生长期肾肿瘤细胞,配制成每管分别含500、200、100、50、10个肿瘤细胞的悬液,与1×106个单个核细胞混合,建立肾癌外周血CTCs模型,AO-F染色后计算肿瘤细胞回收率;另计算2组外周血AO-F+细胞的检出率,分析其与患者临床参数之间的关系。结果肾癌原代肿瘤细胞和细胞系769-P均呈现出鲜明色彩,两者具有相似的形态学特征,平均每个视野下AO-F+细胞占肿瘤细胞的比例为93%±3%。含500、200、100、50个细胞的悬液组肿瘤细胞回收率(%)分别为10.2±3.8、9.2±2.3、10.8±2.6、10.5±1.9,组间差异无统计学意义(P>0.05)。含10个细胞的悬液组偶然可检测到AO-F+细胞。对照组无一例阳性,研究组9例检测到AO-F+细胞,检出率为33.33%;检出率在不同年龄、性别、肿瘤大小、病理类型、Furhman分级、转移部位及带瘤状态间差异均无统计学意义(P>0.05)。结论 AO-F染色法筛查肾癌患者外周血CTCs切实可行,并具有高度的特异性和可重复性,对早期预测肾癌复发转移有一定参考价值。 Objective To establish the screening platform of circulating tumor cells(CTCs) using acridine orange fluo-rescent(AO-F) dyeing method, and to apply it in the screening of peripheral blood CTCs in patients with kidney cancer.Methods Twenty-seven patients with metastatic renal cell carcinoma was included in this study. Primitive tumor cells andkidney cancer cell line 769-P were cultured with different concentrations of fetal bovine serum. Smears were prepared andobserved under fluorescence microscopy. The percentage of AO-F positive staining of 769-P cells under 5 random sightswas calculated. The sensitivity of AO-F staining to cells was evaluated. The 5 m L morning fasting venous blood was obtainedfrom 10 subjects with healthy check-up. The 1×106cell suspension was prepared. The logarithmic phase of renal tumor cellswas used to prepare tube containing 500, 200, 100, 50 and 10 tumor cell suspension, which were mixed with 1×106nucleatedcells to establish CTCs model of renal cancer. AO-F staining method was used to detect the expression of AO-F positivecells. The correlation between expression of AO-F positive cells and clinical parameters was analyzed. Results The prima-ry cells and cell line 769-P showed similar bright color and morphological characteristics. The percentage of AO-F positivestaining in 769-P cells was 93%±3% under 5 random sights. The recovery rates(%) of four groups(500, 200, 100 and 50 tu-mor cell suspension) were 10.2±3.8, 9.2±2.3, 10.8±2.6 and 10.5±1.9, respectively. There were no significant differences inrecovery rates between four groups(P0.05). The group of 10 tumor cell suspension could find AO-F positive staining cellsoccasionally. Zero case was positive in controls. Nine of 27 patients were positive and the rate was 33.33%. There were nosignificant statistical differences in AO- F positive rates between gender, age, tumor size, pathological pattern, Furhmanstage, metastasis of lung and presence of tumor(P〉0.05). Conclusion It is confirmed that the method of CTCs stainingwith AO-F, which has high specificity and reproducibility, is feasible to detect CTCs and worthy of being studied. There is acertain reference value to predict tumor recurrence and metastasis.
出处 《天津医药》 CAS 2015年第7期792-795,共4页 Tianjin Medical Journal
关键词 吖啶橙 显微镜检查 荧光 肾细胞 循环肿瘤细胞 acridine orange microscopy fluorescence carcinoma renal cell circulating tumor cells
  • 相关文献

参考文献11

  • 1Doyen J, Alix-Panabieres C, Hofman P, et al. Circulating tumor ceils in prostate cancer: a potential surrogate marker of survival[J]. Crit Rev Oncol Hematol, 2012, 81(3):241-256. doi: 10.1016/j.crit- revonc.2011.05.004.
  • 2Li J, Zhang Z, Wang J, et al. Urinary cytology with acridine orange fluorescence is highly valuable for predicting high-grade upper urinary tract urothelial carcinoma[J]. Int J Clin Exp Pathol, 2014, 7(2):774-778.
  • 3Hu XC, Chow LW. Fine needle aspiration may shed breast ceils into peripheral blood as determined by RT-PCR[J]. Oncology, 2000, 59 (3):217-222.
  • 4Reid AL, Freeman JB, Millward M, et al. Detection of BRAF-V600E and V600K in melanoma circulating tumour cells by droplet digital PCR[J]. Clin Biochem, 2014 Dec 16. pii: S0009-9120(14)00790-5. doi: 10.1016/j.clinbiochem.2014.12.007.
  • 5Kim YJ, Koo GB, Lee JY, et al. A microchip filter device incorporat- ing slit arrays and 3-D flow for detection of circulating tumor cells using CAV1-EpCAM conjugated microbeads[J]. Biomaterials, 2014, 35(26):7501-7510. doi: 10.1016/j.biomaterials.2014.05.039.
  • 6Gradilone A, Iacovelli R, Cortesi E, et al. Circulating tumor cells and "suspicious objects" evaluated through CellSearch(R) in metastatic renal cell carcinoma[J]. Anticancer Res, 2011, 31(12):4219-4221.
  • 7李燕,李大鹏,马德亮,陶敏,刘海燕.乳腺癌患者循环肿瘤细胞的检测及其临床应用(英文)[J].中国肿瘤外科杂志,2010,2(1):32-38. 被引量:5
  • 8Liu CH, Sahoo SL, Tsao MH. Acridine orange coated magnetic nanoparticles for nucleus labeling and DNA adsorption[J]. Colloids Surf B Biointerfaces, 2014, 115:150- 156. doi: 10.1016/j.col- surfb.2013.11.003.
  • 9李蕾,刘毅,张少华,王涛,边莉,吴世凯,宋三泰,刘兵,江泽飞.循环肿瘤细胞检测在不同阶段不同类型乳腺癌中的应用及意义[J].中华医学杂志,2014,94(36):2812-2815. 被引量:13
  • 10Bluemke K, Bilkenroth U, Meye A, et al. Detection of circulating tu- mor cells in peripheral blood of patients with renal cell carcinoma correlates with prognosis[J]. Cancer Epidemiol Biomarkers Prev, 2009, 18(8):2190-2194.

二级参考文献50

  • 1Jemal A,Siegel R,Ward E,et al.Cancer statistics,2008[J].CA Cancer J Clin,2008,58(2):71-96.
  • 2Chambers AF,Groom AC,MacDonald IC.Dissemination and growth of cancer cells in metastatic sites[J].Nat Rev Cancer,2002,2(8):563-572.
  • 3Pantel K,Brakenhoff RH.Dissecting the metastatic cascade[J].Nat Rev Cancer,2004,4 (6):448-456.
  • 4Ashworth TR.A case of cancer in which cells similar to those in the tumours were seen in the blood after death[J].Aust Med J,1869,14(3):146-149.
  • 5Iakovlev VV,Goswami RS,Vecchiarelli J,et al.Quantitative detectian of circulating epithelial cells by Q-RT-PCR[J].Breast Cancer Res Treat,2008,107(1):145-154.
  • 6Cabioglu N,lgci A,Yildirim EO,et al.An ultrasensitive tumor enriched flow-cytometric assay for detection of isolated tumor cells in bone marrow of patients with breast cancer[J].Am J Surg,2002,184(5):414-417.
  • 7Cruz I,Ciudad J,Cruz JJ,et al.Evaluation of multiparameter flow cytometry for the detection of breast cancer tumor cells in blood samples[J].Am J Clin Pathol,2005,123(1):66-74.
  • 8Pachmann K,Camara O,Kavallaris A,et al.Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse[J].J Clin Oncol,2008,26(8):1208-1215.
  • 9Zabaglo L,Ormerod MG,Parton M,et al.Cell filtration laser scanning cytometry for the characterisation of circulating breast cancer cells[J].Cytometry,2003,55(2):102-108.
  • 10Cristofanilli M,Budd GT,Ellis MJ,et al.Circulating tumor cells,disease progression,and survival in metastatic breast cancer[J].N Engl J Med,2004,351(8):781-791.

共引文献16

同被引文献3

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部